Stivarga Regulatory Post-Marketing Surveillance Study in Korea (StivargaPMS)
Stivarga® Regulatory Post-Marketing Surveillance Study in Korea
Sponsor: Bayer
This observational or N/A phase trial investigates Colorectal Neoplasms and is currently completed. Bayer leads this study, which shows 26 recorded versions since 2014 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
26 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Aug 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Aug 2023 [monthly]
Completed
▶ Show 21 earlier versions
-
May 2020 — Jan 2021 [monthly]
Completed
-
Jul 2019 — May 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jun 2019 — Jul 2019 [monthly]
Active Not Recruiting
-
May 2019 — Jun 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Apr 2019 — May 2019 [monthly]
Recruiting
-
Mar 2019 — Apr 2019 [monthly]
Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Recruiting NA
-
Dec 2017 — Mar 2018 [monthly]
Recruiting NA
-
May 2017 — Dec 2017 [monthly]
Recruiting NA
-
Apr 2017 — May 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .